A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin
Annals of Internal MedicinePublished 7 November 2000
Rebecca J. Beyth, Linda Quinn, C. Seth Landefeld
Citations353
SJR quartileQ1
SJR score3.38
SNIP3.27
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The premise that efforts to reduce the likelihood of major bleeding will lead to safe and effective use of warfarin therapy in older patients is supported, and the generalizability and cost-effectiveness remain to be demonstrated.
Abstract
A multicomponent comprehensive program of warfarin management reduced the frequency of major bleeding in older patients. Although the generalizability and cost-effectiveness of this program remain to be demonstrated, these findings support the premise that efforts to reduce the likelihood of major bleeding will lead to safe and effective use of warfarin therapy in older patients.
Keywords
MedicinePharmacology, Toxicology and Pharmaceutics
Psychological ReviewSelf-efficacy: Toward a unifying theory of behavioral change.
42,551 Citations1977Albert Bandura
Psychological ReviewSelf-efficacy: Toward a unifying theory of behavioral change.
35,454 Citations1977Albert Bandura
An integrative theoretical framework to explain and to predict psychological changes achieved by different modes of treatment is presented and findings are reported from microanalyses of enactive, vicarious, and emotive mode of treatment that support the hypothesized relationship between perceived self-efficacy and behavioral changes.
Thrombosis and HaemostasisA Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
2,058 Citations1993F.R. Rosendaal, Suzanne C. Cannegieter +2 more
This method allows the determination of the optimal pharmacological effects of anticoagulation, which can form a rational starting point for choosing the target levels in subsequent clinical trials.
The LancetPLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION
1,826 Citations1989Palle Petersen, J Godtfredsen +3 more
The incidence of thromboembolic complications and vascular mortality were significantly lower in the warfarin group than in the aspirin and placebo groups, which did not differ significantly.
CHEST JournalOral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
1,798 Citations2001J. Hirsh, James E. Dalen +5 more
The mainstay treatment for atrial fibrillation is Coumadin Aspirin Reinfarction, but the use of aspirin for other reasons is also being considered.
CirculationStroke Prevention in Atrial Fibrillation Study. Final results.
1,712 Citations1991
Aspirin and warfarin are both effective in reducing ischemic stroke and systemic embolism in patients with atrial fibrillation and patients with nonrheumatic atrialfibrillation who can safely take either aspirin or warfarIn should receive prophylactic antithrombotic therapy to reduce the risk of stroke.
New England Journal of MedicineThe Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1,535 Citations1990Daniel E. Singer
Long-term low-dose warfarin therapy is highly effective in preventing stroke in patients with non-rheumatic atrial fibrillation, and can be quite safe with careful monitoring.
PubMedExpanding patient involvement in care. Effects on patient outcomes.
1,388 Citations1985Sheldon Greenfield, S Kaplan +1 more
The LancetBleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
1,338 Citations1996Gualtiero Palareti, Nicoletta Leali +11 more
Caution is required in elderly patients and anticoagulation intensity should be closely monitored to reduce periods of overdosing and see fewer bleeding events than those recorded in other observational and experimental studies.
New England Journal of MedicineWarfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
1,167 Citations1992Michael D. Ezekowitz, Samuel L. Bridgers +11 more
Low-intensity anticoagulation with warfarin prevented cerebral infarction in patients with nonrheumatic atrial fibrillation without producing an excess risk of major hemorrhage, and this benefit extended to patients over 70 years of age.
Journal of the American College of CardiologyCanadian atrial fibrillation anticoaguiation (CAFA) study
1,119 Citations1991Stuart J. Connolly, Andreas Laupacis +4 more
Journal of General Internal MedicinePatients’ participation in medical care
1,112 Citations1988Sheldon Greenfield, Sherrie H. Kaplan +3 more
The authors conclude that the intervention is feasible and that it changes patient behavior, improves blood sugar control, and decreases functional limitations.
New England Journal of MedicineA New Design for Randomized Clinical Trials
1,039 Citations1979Marvin Zelen
This paper proposes a new method for planning randomized clinical trials, especially suited to comparison of a best standard or control treatment with an experimental treatment, which has the advantage that, before providing consent, a patient will know whether an experimental therapy is to be used.
The American Journal of MedicineAnticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
892 Citations1993C. Seth Landefeld, Rebecca J. Beyth
The risk for bleeding can be estimated in an individual patient, giving the primary physician a quantitative basis for weighing the risks and benefits of therapy and for optimizing patient management.
The American Journal of MedicineProspective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
776 Citations1998Rebecca J. Beyth, Linda Quinn +1 more
The Outpatient Bleeding Risk Index prospectively classified patients according to risk of major bleeding and performed better than physicians and may be preventable in many high-risk patients by avoidance of over-anticoagulation and nonsteroidal anti-inflammatory agents.
The American Journal of MedicineMajor bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy
766 Citations1989C. Seth Landefeld, Ohio Lee Goldman
These findings provide a quantitative basis for evaluating the risk of major bleeding in individual patients at the start of outpatient therapy with warfarin and identify predictive factors known at the beginning of therapy.
New England Journal of MedicineDifferent Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
735 Citations1982R. Hull, J. Hirsh +10 more
It is indicated that less intense anticoagulant therapy is associated with a low frequency of recurrent venous thromboembolism and a reduced risk of hemorrhage.
Annals of Internal MedicineRisk Factors for Complications of Chronic Anticoagulation: A Multicenter Study
671 Citations1993Stephan D. Fihn, Mary McDonell +6 more
The incidence of bleeding and thromboembolic complications and related risk factors from a retrospective study of 980 patients followed in five anticoagulation clinics through 1990 are described.
Archives of Internal MedicineComparison of an Anticoagulation Clinic With Usual Medical Care
594 Citations1998Elaine Chiquette, Mary G. Amato +1 more
A clinical pharmacist-run AC improved anticoagulation control, reduced bleeding and thromboembolic event rates, and saved $162058 per 100 patients annually in reduced hospitalizations and emergency department visits.
Annals of Internal MedicineThe Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin
557 Citations1996Stephan D. Fihn, Catherine M. Callahan +4 more
This study analyzed data from six anticoagulation clinics to determine whether elderly patients who were receiving warfarin had a higher incidence of complications than similar younger patients who are also receiving warFarin.
Archives of Internal MedicineBleeding complications in oral anticoagulant therapy. An analysis of risk factors
542 Citations1993F J van der Meer
The risk of bleeding complications rises significantly with age and with the achieved intensity of anticoagulation, and is dependent on the type of coumarin derivative that is used.
Archives of Internal MedicineBleeding Complications in Oral Anticoagulant Therapy
433 Citations1993F.J.M. van der Meer
The risk of bleeding complications rises significantly with age and with the achieved intensity of anticoagulation, and is dependent on the type of coumarin derivative that is used.
New England Journal of MedicineTrial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart Valves
371 Citations1990Jalal Saour, Jens O. Sieck +2 more
It is concluded that a moderate anticoagulant effect in patients with a mechanical prosthetic heart valve offers protection equivalent to that of more intensive therapy, but at a significantly lower risk.
Medical CarePatient Adherence to Prescribed Therapies
345 Citations1985Marshall H. Becker
At least four factors are essential to the success of outpatient therapy: recognition of ill health; diagnosis of illness; planning of treatment; and the patient's adherence (or "compliance") to the therapeutic plan.
Archives of Internal MedicineHemorrhagic Complications of Anticoagulant Therapy
311 Citations1974William W. Coon
The frequency of bleeding increased with the intensity of treatment as reflected in daily determinations of "prothrombin activity," and epidemiologic factors possibly associated with an increased risk of bleeding included advanced age, urologic disorders, gynecologic problems, the postpartum state, and the initiation of therapy by administration of large oral doses of anticoagulant.
Mayo Clinic ProceedingsBleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, Minnesota
276 Citations1995Michael Gitter, Thomas M. Jaeger +3 more
In this population-based study, including a high proportion of elderly patients, malignant disease at initiation of warfarin anticoagulation was significantly associated with both major hemorrhage and any thromboembolism.
The American Journal of MedicineIdentification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy
266 Citations1987C. Seth Landefeld, E. Francis Cook +3 more
Among 617 hospitalized patients who started long-term anticoagulant therapy, major bleeding developed before discharge in 28 patients and minor bleeding in another 38, with daily incidence rates of 0.4 and 0.5 percent, respectively.
Archives of Internal MedicinePhysician Attitudes About Anticoagulation for Nonvalvular Atrial Fibrillation in the Elderly
233 Citations1995Douglas C McCrory
Anticoagulant therapy may be less often and less intensively used for elderly patients with nonvalvular atrial fibrillation.
Archives of Internal MedicineNational Patterns of Warfarin Use in Atrial Fibrillation
211 Citations1996Randall S. Stafford
Although it is unrealistic to expect universal warfarin use, the 1992 and 1993 rate of 32% is probably suboptimal given the benefit of anticoagulation in preventing embolic strokes.
HeartA 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment.
198 Citations1979J C Forfar
Outpatients treated between 1970 and 1977, comprising 1199 patient-years of treat-ment, have been analysed in an attempt to clarify the iatrogenic risks of haemorrhage associated with oral anticoagulant treatment.
Annals of Internal MedicineHome Prothrombin Time Monitoring after the Initiation of Warfarin Therapy
191 Citations1989Richard H. White, Stephen A. McCurdy +3 more
Use of a portable prothrombin time monitor by patients at home is feasible and provides accurate measurements, and patients doing home monitoring achieve superior anticoagulation control compared with those receiving standard antICOagulation clinic care.
Journal of Internal MedicineBleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients
171 Citations1991J Launbjerg, Henrik Egeblad +4 more
Although no lethal episodes of bleeding occurred, the developing field of indications for oral anticoagulant therapy should be considered on the basis of a continuous substantial risk of major bleeding.
Journal of General Internal MedicineRisk of major hemorrhage for outpatients treated with warfarin
155 Citations1998Deborah McMahan, David M. Smith +2 more
The incidence ofmajor hemorrhage in this population of outpatients treated with warfarin was lower than previous estimates of major hemorrhage measured before the recommendation for reduced-intensity anticoagulation therapy was made, but still higher than estimates reported from clinical trials.
American Heart JournalEvolving models of warfarin management: Anticoagulation clinics, patient self-monitoring, and patient self-management
152 Citations1996Jack Ansell, R. Hughes
Archives of Internal MedicineEvaluation of a Portable Prothrombin Time Monitor for Home Use by Patients Who Require Long-term Oral Anticoagulant Therapy
152 Citations1993David R. Anderson
The use of the portable monitor as the primary method for measuring the PT can be recommended in selected patients receiving long-term anticoagulant treatment.
Archives of Internal MedicinePhysicians' Attitudes Toward Oral Anticoagulants and Antiplatelet Agents for Stroke Prevention in Elderly Patients With Atrial Fibrillation
152 Citations1991Morris Kutner
It is concluded that physicians are still hesitant to use oral anticoagulants and antiplatelet agents for the prevention of strokes in their elderly patients with atrial fibrillation.
Journal of General Internal MedicineFailure to prescribe warfarin to patients with nonrheumatic atrial fibrillation
121 Citations1996Meghal R. Antani, Rebecca J. Beyth +6 more
Warfarin was prescribed infrequently to these patients with nonrheumatic atrial fibrillation, especially the older patients and even the patients for whom warfar in was judged appropriate, indicating a substantial opportunity to prevent stroke.
Journal of General Internal MedicineWhy isn’t warfarin prescribed to patients with nonrheumatic atrial fibrillation?
116 Citations1996Rebecca J. Beyth, Meghal R. Antani +5 more
Physicians’ opinions frequently opposed warfarin for older patients with nonrheumatic atrial fibrillation, and for those with bleeding risk factors, most likely contribute to its infrequent prescription.
Archives of Internal MedicineManagement of Oral Anticoagulant Therapy
99 Citations1984Anne Marie Errichetti
The experience acquired in an anticoagulation clinic during 4 1/2 years is reviewed to demonstrate the effectiveness of such a clinic and to provide the practicing physician with guidelines for managing outpatient oral antICOagulation therapy.
Archives of Internal MedicineReliance on Prothrombin Time Ratios Causes Significant Errors in Anticoagulation Therapy
93 Citations1992Henry I. Bussey
Warfarin therapy in the United States is managed inappropriately because most laboratories do not report INRs and the variability in thromboplastin sensitivity produces misleading prothrombin time ratio results.
American Journal of Clinical PathologyA Novel Whole Blood Capillary Technic for Measuring the Prothrombin Time
92 Citations1987Fred V. Lucas, Alexander Duncan +7 more
A recently developed capillary whole blood device that uses fingerstick samples was evaluated and appears to be comparable in accuracy to current reference methods.
Archives of Internal MedicinePatient Self-Management of Oral Anticoagulation Guided by Capillary (Fingerstick) Whole Blood Prothrombin Times
90 Citations1989Jack Ansell
This pilot study suggests that patient self-management of warfarin therapy based on fingerstick prothrombin times is feasible and that this model of anticoagulant care offers the potential for improved care at reduced cost.
Archives of Internal MedicineManagement of Anticoagulation in Outpatients
89 Citations1977Faith B. Davis
In 66 months, a general hospital's outpatient Anticoagulation Service (ACS) monitored 263 patients who received 280 courses of warfarin sodium totalling 254 patient treatment years, attributing a favorable experience with outpatient ACS to careful patient selection, patient education and monitoring, attention to duration of anticoagulations, and continuing communication with primary physicians who retained responsibility for medical care.
Archives of Internal MedicineManagement and Prognosis of Life-threatening Bleeding During Warfarin Therapy
88 Citations1996Richard H. White
The incidence of life-threatening bleeding was rare, the gastrointestinal tract was the site of bleeding in two thirds of the patients who experienced life- threatening bleeding, most patients who received warfarin therapy had multiple risk factors for bleeding, including excessive anticoagulation, and the risk of subsequent bleeding was extremely high among patients who continued to receive warfar in therapy.
Thrombosis and HaemostasisQuestions and Answers on Prothrombin Time Standardisation in Oral Anticoagulant Control
87 Citations1985E.A. Loeliger, L. Poller +5 more
The new system of reporting the level of anticoagulation was designed and can only safely be applied in patients taking oral antICOagulants.
Archives of Internal MedicinePhysician Variation in Anticoagulating Patients With Atrial Fibrillation
86 Citations1990Huan J. Chang
Investigation of variations in the oral anticoagulant treatment of atrial fibrillation by physicians in three specialties showed general agreement in the antICOagulation decision regarding patients with either mitral valve disease or a history of chronic alcohol abuse, but substantial disagreement in other categories of patients.
Journal of the American Geriatrics SocietyUnderutilization of Warfarin in Older Persons with Chronic Nonvalvular Atrial Fibrillation at High Risk for Developing Stroke
85 Citations1998Gad Mendelson, Wilbert S. Aronow
To investigate the prevalence of the use of warfarin to maintain an international normalized ratio (INR) between 2.0 and 3.0 in older persons with chronic nonvalvular atrial fibrillation and without contraindications towarfarin, who are at high risk for developing new thromboembolic stroke.
Journal of Clinical EpidemiologyThe bleeding severity index: Validation and comparison to other methods for classifying bleeding complications of medical therapy
85 Citations1989C. Seth Landefeld, Philip A. Anderson +5 more
It is concluded that the classification of bleeding complications of medical therapy depends on the method used and the bleeding severity index is highly reproducible and should be tested more widely to determine whether it can be applied to the burgeoning clinical research in anticoagulation and thrombolysis.
The American Journal of MedicineA bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy
85 Citations1990C. Seth Landefeld, Edward J. McGuire +1 more
The bleeding risk index provides valid estimates of the probability of major bleeding in hospitalized patients starting long-term anticoagulant therapy and complements physicians' predictions, and the possibility that bleeding can be prevented in high-risk patients warrants prospective evaluation.
Archives of Internal MedicineAccuracy and Precision of a Portable Anticoagulation Monitor in a Clinical Setting
83 Citations1992Stephen A. McCurdy
The monitor differed systematically from the laboratory and was moderately less precise; the magnitude of these effects was not great, however, and accuracy was best at around INR = 3.0, the border between low and high therapeutic ranges.
Journal of Clinical EpidemiologyProthrombin time ratio and other factors associated with bleeding in patients treated with warfarin
77 Citations1989Diana B. Petitti, Brian L. Strom +1 more
Archives of Internal MedicineRegional Attitudes of Generalists, Specialists, and Subspecialists About Management of Atrial Fibrillation
76 Citations1996Michael A. Brodsky
Physicians ranging from primary care providers to subspecialists agree on issues of AF management such as heart rate control and anticoagulation, but attitudes vary widely about issues such as antiarrhythmic drugs.
Drugs & AgingAnticoagulants in Older Patients
75 Citations1995Rebecca J. Beyth, C. Seth Landefeld
Findings provide a basis for weighing the risks of anticoagulant therapy and for making decisions about the use of antICOagulants in older patients and indicate the potential value of methods to decrease the frequency of anticonvulsant-related bleeding in Older patients.
Annals of Internal MedicineGuideline-based Consultation To Prevent Anticoagulant-related Bleeding
56 Citations1992C. Seth Landefeld, Philip A. Anderson
Guidelines-based consultation was associated with reduction in the frequency of anticoagulant-related bleeding in patients at increased risk for major in-hospital bleeding and improved housestaff learning.
Archives of Internal MedicinePhysician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project
55 Citations1990Hyuk‐Jae Chang
Investigation of variations in the oral anticoagulant treatment of atrial fibrillation by physicians in three specialties showed general agreement in the antICOagulation decision regarding patients with either mitral valve disease or a history of chronic alcohol abuse, but substantial disagreement in other categories of patients.
International Journal of CardiologyAnticoagulation clinics and the monitoring of anticoagulant therapy
46 Citations1988Richard Charney, Elaine Leddomado +2 more
Patients attending an anticoagulation clinic were studied to delineate predisposing risk factors for bleeding and thromboembolic episodes and the average prothrombin time ratio during the third to the sixth month of therapy was predictive of the bleeding risk.
PubMedEvaluation of a capillary whole-blood prothrombin time measurement system.
33 Citations1989Weibert Rt, Adler Ds
Presentation d'un systeme de mesure immediate du temps de prothrombine, par analyse du sang obtenu par piqure du doigt et comparative aupres des patients entre l'utilisation routiniere du systeme et the methode usuelle de mesur en laboratoire.
PubMedStandardizing the prothrombin time. Calibrating coagulation instruments as well as thromboplastin.
25 Citations1993Daniel M. Becker, John Eric Humphries +4 more
It is concluded that the instrumentation effect may be clinically meaningful, and coagulation instruments as well as thromboplastins should be calibrated to standardize warfarin therapy.